Listed below are the current guidelines, provisional clinical opinions, endorsements, and updates in development. Topics prioritized for development by the Clinical Practice Guidelines Committee and Guideline Advisory Groups are listed by disease site. To submit a topic for consideration, take our survey. To learn more about the ASCO Guideline development process, access the Guideline Methodology page.

Guidelines/Provisional Clinical Opinions (PCOs)/Endorsements in Development

Breast Cancer

Gastrointestinal Cancer

  • Management of Localized and Locally Advanced Esophageal Adenocarcinoma and Squamous Cell Carcinoma
  • Systemic Therapy for Advanced Hepatocellular Carcinoma
  • Update: Stage II Colon Cancer

Genitourinary Cancer

Gynecologic Cancer

  • Germline and Somatic Tumor Testing in Ovarian Cancer
  • PARP Inhibitors for Ovarian Cancer

Head and Neck Cancer

  • Unknown Primary in Head and Neck Cancer

Melanoma

  • Systemic Therapy for Melanoma

Neurooncology

  • Treatment of Patients with Brain Metastases
  • Management of Glioma

Resource Stratified

  • Treatment for Invasive Colorectal Cancer
  • Treatment of Ovarian Cancer

Supportive Care

Survivorship

Thoracic

Standards

  • Oral Dispensing Standards

Multi-Site

  • Somatic Genomic Panel Testing for Metastatic Disease

Guideline Priorities 2018-2019

Breast Cancer

Gastrointestinal Cancer

  • Advanced (Metastatic) Colon Cancer
  • Treatment Options for Well-Differentiated Neuroendocrine Tumors
  • Systemic Therapy for Advanced Gastric Cancer
  • Neoadjuvant and Adjuvant Therapy for Rectal Cancer, Including Watchful Waiting

Genitourinary Cancer

  • Special Considerations for Elderly Patients With Genitourinary Cancers
  • Cytoreductive Nephrectomy and Metastasis Directed Therapy and Treatment for Advanced Clear Cell Renal Carcinoma
  • Primary Tumor-Directed and Metastasis-Directed Local Therapy in Metastatic Prostate Cancer
  • Update: Muscle-Invasive and Metastatic Bladder Cancer

Gynecologic Cancer

  • First Platinum-Sensitive Ovarian Cancer Recurrence
  • Chemotherapy for Women With Advanced Stage Ovarian/Primary Peritoneal/Fallopian Tube Cancer Following Upfront Surgical Cytoreduction and Front-Line Maintnenance
  • Fertility Sparing Treatment Options for Reproductive Aged Women With Gynecologic Cancers
  • Update: Neoadjuvant Chemotherapy for Ovarian Cancer

Head and Neck Cancer

  • Management of Salivary Gland Malignancy
  • Management of Locoregionally Recurrent Head and Neck Cancer
  • Use of TORS in the Management of Head and Neck Cancer

Multi-Site

  • Germline Genetic Testing
  • Adjuvant Therapy for Soft-Tissue Sarcoma
  • Management of Untreated Follicular Lymphoma

Resource Stratified

Supportive Care

Survivorship

  • Cognitive Dysfunction in Cancer Survivors
  • Lymphedema in Post-Treatment Cancer Survivors
  • Sleep Problems in Cancer Survivors
  • Exercise, Weight, and Obesity in Post-Treatment Cancer Survivors
  • AYA Cancer Survivorship

Thoracic

  • Stage IV Non-Small-Cell Lung Cancer (NSCLC) - Driver Mutations
  • Management of Brain Metastases and Leptomeningeal Metastases in NSCLC Patients
  • Management for Stage III NSCLC
  • Next Generation Sequencing and Other Mutliplex Testing Platforms in Tissue and Blood for Detection of Oncogenic Drivers in Metastatic NSCLC
  • Management of Oligometastasis and Oligoprogressive Disease

Recently Published Guidelines